CR Medicon is proud to be a sponsor of Medidata NEXT 2019 in New York City, the industry’s leading forward-thinking and networking conference that drives industry trends while enabling participates to experience the latest technology on the unified Medidata platform.
Dr. Henry Wu (CEO), Mr. Charles Li (VP, Business Development, US), Dr. Pei-Yun Chen (Sr. Director of Biostatisitics & US site head) from CR Medicon will attend Medidata NEXT 2019 New York and be invited speakers in Track One: Best Practices of Clinical Trial of Today. Connect up with Charles https://lnkd.in/eShFiMR and let him know if you are going or will be around town. We’d love to shake hands and say hello!
About NEXT NYC
NEXT NYC drives forward-thinking conversations, highlights influential voices, and ultimately, spurs real action to improve patient lives. We invite you to participate in the conversations driving industry trends while experiencing the latest technology on the unified Medidata platform. You will network with a distinct audience of tech adopters, decision makers, and trial trendsetters. Check out the highlights from our 2018 program below! The conference is free to attend for our customers and qualified members of the life science ecosystem. Space is limited – claim your seat today. We’ll keep you posted as our agenda develops. Stay tuned for updates on sponsorship opportunities, call for abstracts, hotel information, and more.
NEXT NYC offers attendees unparalleled opportunities to:
About CR Medicon
CR Medicon (https://en.crmedicon.com) is a global clinical Contract Research Organization from China with global innovative clinical development in mind. Services we provide at CR Medicon include: Regulatory Affairs, Medical Affairs, Clinical Operations, Biometrics (Data Management, Statistical Analysis, Statistical Programming), Bioanalysis, and Pharmacovigilance, etc. Decades of experience both in the US and China, our professional team is capable of delivering world-class, best quality services to our clients with the highest efficiency. Being the world’s fastest growing clinical development organization, we have attracted hundreds of talents, to take care of our clients, to share the responsibility of getting the best medical products to the patients better, safer and faster. At present, CR Medicon has more than three hundred full-time, well trained staff, serving over one hundred sponsors all over the world.
About CR Medicon CR Medicon provides a full range of clinical development services, including drug and equipment registration, medical affairs, clinical operations, biological sample analysis, drug alert, data management and statistical analysis, of which the eCTD system is an integral part of our one-stop clinical CRO services. Since our founding in 2017, CR Medicon has become the clinical CRO partners for nearly a hundred well-known domestic and foreign biotech and pharmaceutical enterprises. CR Medicon team brings together the industry’s experts, has extensive experience in phase I-III new drug clinical, medical device and BE trials. and has been involved in clinical trial monitoring and project management in cutting-edge areas.